Pharmaceutical Industry

Page 49 of 100

BioGen Alzheimers
Health

Biogen’s Stock Is Soaring Because of Its Experimental Alzheimer’s Drug — But Some Are Urging Caution

By
July 6, 2018
Pfizer Raises Prices on Prescription Drugs Like Viagra and Chantix for the Second Time This Year
Health

Pfizer Raises Prices on Prescription Drugs Like Viagra and Chantix for the Second Time This Year

By
July 2, 2018
Flu clinic
Health

This New Single Dose Flu Drug Could Be Coming to the U.S. Before the Next Flu Season

By
June 28, 2018
Sativex is a cannibanoid medecine manufactured by GW Pharmaceuticals. This mouth spray has just received approval to be launched on the French market, for limited use on patients suffering from multiple sclerosis.
Health

This Company Made the First FDA Approved, Marijuana Based Drug. Here’s What It Wants to Do Next

By
June 27, 2018
Alzheimers-dementia-brain-research
Health

The AARP, UnitedHealth, and Quest Diagnostics Are Pouring $75 Million Into Fighting Alzheimer’s and Dementia

By
June 26, 2018
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health

Why Sarepta Stock Skyrocketed 40% Today

By
June 19, 2018
Coins2Day
Retail

Walgreens to Open Senior Care Centers With Humana

By
June 19, 2018
Pedestrians walk by a CVS store on November 5, 2013 in San Francisco, California.
Retail

CVS Launches Drug Delivery Nationwide as Amazon Threat Looms

By
June 19, 2018
CHINA-ECONOMY-CREDI-LOANS-DEBT-GOVERNMENT
Health

A Cancer Blockbuster Gets Approved in China. Will the Floodgates Now Open?

By
June 15, 2018
Alzheimers-dementia-brain-research
Health

Eli Lilly, AstraZeneca’s Alzheimer’s Drug Flop Is the Latest Disappointment in a Frustrating Disease

By
June 12, 2018
President Trump Signs "Right To Try" Act
Health

Trump Predicts ‘Massive Drops in Prices’ for Drugs. Here’s Why That Probably Won’t Happen

By
May 30, 2018
Express Scripts To Buy Medco For $29.1 Billion To Gain Scale
Health

The Drug Industry’s Middlemen Are in the Hot Seat

By
May 21, 2018
Headache senior
Health

FDA Approves New Migraine Drug: What You Need to Know

By
May 18, 2018
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
Health

The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising

By
May 18, 2018
The American Enterprise Institute photo of Scott Gottlieb
Health

The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs

By
May 17, 2018

Most Popular